AI assistant
Sending…
HARROW, INC. — Director's Dealing 2020
Mar 18, 2020
31774_dirs_2020-03-18_2c043c25-1590-41d7-93fb-a30d9bd8ea38.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2020-03-16
Reporting Person: AUSTIN STEPHEN G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-16 | COMMON STOCK | M | 72218 | — | Acquired | 91987 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-03-16 | RSU | $0 | M | 9715 | Disposed | Common Stock (9715) | Direct | |
| 2020-03-16 | RSU | $0 | M | 34091 | Disposed | Common Stock (34091) | Direct | |
| 2020-03-16 | RSU | $0 | M | 15723 | Disposed | Common Stock (15723) | Direct | |
| 2020-03-16 | RSU | $0 | M | 12690 | Disposed | Common Stock (12690) | Direct |
Footnotes
F1: The Reporting Person was awarded Restricted Stock Units for his service as director of the Company that vested quarterly in equal installments over a one-year periods following the date of grant. The shares underlying such Restricted Stock Units were deferred to the Reporting Person until his resignation from the Company's board of directors.
F2: The Restricted Stock Units were received as a compensatory award for no consideration.
More from HARROW, INC.
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 8